Clinical trials
Herpes Zoster clinical trials
Below are recruiting herpes zoster clinical trials, each written for real people, not researchers. We’re tracking 39 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06088745RecruitingPhase 3
Shingles vaccine trial for adults 40+
This trial tests a new shingles vaccine to see how well it prevents shingles in adults aged 40 and older. It aims to help those who have not had shingles recently or been vaccinated against it before.
Zhenjiang, JiangsuAges 40 years+ - NCT06643247Recruiting
Electroacupuncture for shingles pain and immune response
This study tests if electroacupuncture can help calm the immune system and reduce shingles pain. It is for women aged 50–70 who have had a shingles rash for 7 days or less and have not yet taken any medication for their shingles.
Hangzhou, ZhejiangAges 50–70 - NCT06903078Recruiting
Shingles and Dementia Risk Study
This study looks at whether the virus that causes shingles (herpes zoster) might increase the risk of dementia. Participants with a fresh shingles rash will give blood samples and attend several follow-up visits over one year.
Houston, TexasAges 18 years+ - NCT06932523RecruitingPhase 1/Phase 2
Shingles vaccine study for healthy adults
This trial tests a new shingles vaccine for healthy adults 40 and older. It aims to see if the vaccine is safe and helps protect against shingles.
Wuhan, HubeiAges 40 years+ - NCT07099157RecruitingPhase 4
Brivudine for Shingles: Safety and Effectiveness Study
This trial tests whether the antiviral drug brivudine is safe and effective for treating shingles (herpes zoster). It compares brivudine to other antiviral treatments like famciclovir, and may be an option if you are looking for a shorter treatment course.
BeijingAges 18 years+ - NCT07307170Recruiting
Mirogabalin for shingles pain study
This trial tests a new pain medicine called mirogabalin for people with shingles pain that started within the last 30 days. It aims to see if the drug can safely reduce moderate to severe pain.
BeijingAges 18 years+ - NCT07307976Recruiting
Testing a new pain drug for shingles pain
This trial tests a new medicine called crisugabalin to see if it safely reduces shingles pain. It may help if you have moderate to severe pain from a shingles rash that started less than 3 months ago.
BeijingAges 18 years+ - NCT07361796Recruiting
Preventing nerve pain after shingles with venlafaxine
This trial tests if the antidepressant venlafaxine can prevent long-term nerve pain (postherpetic neuralgia) in people who currently have shingles. If you have moderate to severe shingles pain, this study may help find a way to stop the pain from becoming chronic.
BeijingAges 18 years+ - NCT07361809Recruiting
Desvenlafaxine for shingles pain relief
This trial tests if desvenlafaxine (an antidepressant also used for nerve pain) can safely reduce pain from shingles. It may be an option if your shingles pain is moderate to severe and started within the last 3 months.
BeijingAges 18 years+ - NCT07370389Recruiting
Testing a new pain drug for shingles pain
This trial tests a new pain medication called tulodesvenlafaxine for people with shingles-related pain. It may help if you have moderate to severe pain that started within the last 90 days.
BeijingAges 18 years+ - NCT07370402Recruiting
Flurbiprofen patch for shingles pain relief
This trial tests if a flurbiprofen skin patch can reduce pain from shingles (herpes zoster). It may help people with moderate to severe pain who have had the rash for less than 90 days.
BeijingAges 18 years+ - NCT07378046Recruiting
Baclofen for shingles pain: a safety and effectiveness study
This study tests whether the muscle relaxant baclofen can safely reduce shingles pain. It is for adults with moderate to severe pain who have not tried this drug before.
BeijingAges 18 years+ - NCT07378059Recruiting
Loxoprofen patch for shingles pain
This trial tests if a loxoprofen skin patch (a non-steroidal anti-inflammatory drug) can safely relieve moderate to severe pain from shingles. It may be an option for people who have had shingles rash for less than 90 days.
BeijingAges 18 years+ - NCT07585370Recruiting
Long-term Safety and Effectiveness of Shingles Vaccine
This study follows up with people who received an experimental shingles vaccine (a live, weakened form of the virus) in a previous trial from 2020–2021. Researchers want to understand how well the vaccine continues to protect against shingles over time.
Nanjing, JiangsuAges 40 years+ - NCT07633197Enrolling by invitationPhase 1
Testing a new shingles vaccine for adults over 40
This study tests a new vaccine to protect against shingles (herpes zoster), a painful skin infection that can affect people as they age. You would receive the vaccine and be monitored to see if it's safe and how your body responds.
Zhengzhou, HenanAges 40 years+ - NCT06449547Recruiting
Risk factors for anxiety and depression in shingles nerve pain
This study looks at what makes people with shingles nerve pain more likely to feel anxious or depressed. By joining, you'll help doctors understand how to better support patients like you.
Wuhan, HubeiAges 18 years+ - NCT07655804RecruitingPhase 3
Calcitonin injection for shingles pain in older adults
This trial tests whether a medication called calcitonin (given as a shot under the skin) can help reduce pain in people with a recent shingles outbreak. It is for adults 50 and older who have moderate to severe pain from their rash.
Tanta, Gharbia GovernorateAges 50 years+ - NCT06942806Recruiting
Spinal cord stimulation for shingles nerve pain
This trial tests a treatment called high-frequency short-time spinal cord stimulation for pain caused by shingles (herpes zoster). It's for people whose pain hasn't improved with other treatments or who can't take pain medicines due to side effects or other health issues.
Zunyi, GuizhouAges 40–85 - NCT06959147RecruitingPhase 4
Study for nerve pain after shingles using radiofrequency and a numbing shot
This trial tests a two-step procedure for treating nerve pain after shingles (called postherpetic neuralgia). First, a special type of radiofrequency treatment is applied to block the pain signals. Then, a long-lasting numbing medicine is injected under the skin to help keep the pain away. It is for people aged 40 to 85 who have not gotten enough relief from standard medicines.
Zunyi, GuizhouAges 40–85 - NCT07400003RecruitingPhase 1/Phase 2
Shingles mRNA vaccine safety and immune response study
This trial tests a new mRNA vaccine to prevent shingles (herpes zoster). It checks if the vaccine is safe and helps your body build immunity. It's for adults aged 40 or older (phase 1) or 50+ (phase 2).
XinjiangAges 40 years+ - NCT06969417Recruiting
Comparing two medications for shingles nerve pain
This trial compares two medications (pregabalin and lacosamide) to find out which works better for relieving nerve pain that continues after shingles. If you have this persistent pain and are not already on painkillers, you may be able to join.
Kharan, Punjab ProvinceAges 18–50 - NCT05559671RecruitingPhase 4
Shingles vaccine safety study for people with lupus
This Phase 4 study checks how safe a shingles vaccine (Shingrix, a non-live vaccine) is for adults with lupus. You might be invited if you have lupus and haven’t had certain shingles or chickenpox-related vaccines recently, and if your lupus symptoms and immune health meet the study rules.
New York, New YorkAges 18–90 - NCT07515885Recruiting
Electroacupuncture for Shingles Pain Relief
This study tests whether electroacupuncture (a form of acupuncture with mild electrical stimulation) can reduce pain from shingles (herpes zoster), a viral infection that causes painful skin rashes. Researchers will also measure certain markers in your blood to understand how the treatment works.
Hangzhou, ZhejiangAges 20–80 - NCT06137755RecruitingPhase 1
Shingles vaccine study for healthy adults 50-65
This trial tests a new shingles vaccine in healthy adults aged 50 to 65. Shingles can cause a painful rash, and the vaccine aims to prevent it.
Seoul, Eunpyeong-guAges 50–64
Hear when a new Herpes Zoster trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for herpes zoster?
- Yes. Clin2 currently lists 39 recruiting herpes zoster studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a herpes zoster trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a herpes zoster trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.